🚀 VC round data is live in beta, check it out!
Inner Mongolia Furui Medical Science Valuation Multiples
Discover revenue and EBITDA valuation multiples for Inner Mongolia Furui Medical Science and similar public comparables like Shandong Weigao Blood, Dentsply Sirona, Chengzhi, Schott Pharma and more.
Inner Mongolia Furui Medical Science Overview
About Inner Mongolia Furui Medical Science
Inner Mongolia Furui Medical Science Co Ltd is a China based medical service platform company. It provides disease diagnosis, drug treatment and chronic disease management centered on the liver disease field. The product portfolio of the company includes tablets, capsules, and plaster. In addition, the company is also engaged in providing health-care services.
Founded
1998
HQ
Employees
330
Website
Sectors
Financials (LTM)
EV
$2B
Inner Mongolia Furui Medical Science Financials
Inner Mongolia Furui Medical Science reported last 12-month revenue of $250M.
In the same LTM period, Inner Mongolia Furui Medical Science generated $189M in gross profit and $25M in net income.
Revenue (LTM)
Inner Mongolia Furui Medical Science P&L
In the most recent fiscal year, Inner Mongolia Furui Medical Science reported revenue of $234M and EBITDA of $67M.
Inner Mongolia Furui Medical Science expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $250M | XXX | $234M | XXX | XXX | XXX |
| Gross Profit | $189M | XXX | $175M | XXX | XXX | XXX |
| Gross Margin | 76% | XXX | 75% | XXX | XXX | XXX |
| EBITDA | — | XXX | $67M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 29% | XXX | XXX | XXX |
| EBIT Margin | 24% | XXX | 25% | XXX | XXX | XXX |
| Net Profit | $25M | XXX | $23M | XXX | XXX | XXX |
| Net Margin | 10% | XXX | 10% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Inner Mongolia Furui Medical Science Stock Performance
Inner Mongolia Furui Medical Science has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
Inner Mongolia Furui Medical Science's stock price is $8.35.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | 0.0% | XXX | XXX | XXX | $0.09 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialInner Mongolia Furui Medical Science Valuation Multiples
Inner Mongolia Furui Medical Science trades at 8.5x EV/Revenue multiple, and 31.9x EV/EBITDA.
EV / Revenue (LTM)
Inner Mongolia Furui Medical Science Financial Valuation Multiples
As of April 19, 2026, Inner Mongolia Furui Medical Science has market cap of $2B and EV of $2B.
Equity research analysts estimate Inner Mongolia Furui Medical Science's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Inner Mongolia Furui Medical Science has a P/E ratio of 89.6x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 8.5x | XXX | 9.1x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 31.9x | XXX | XXX | XXX |
| EV/EBIT | 36.2x | XXX | 36.4x | XXX | XXX | XXX |
| EV/Gross Profit | 11.3x | XXX | 12.2x | XXX | XXX | XXX |
| P/E | 89.6x | XXX | 98.0x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 89.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Inner Mongolia Furui Medical Science Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Inner Mongolia Furui Medical Science Margins & Growth Rates
Inner Mongolia Furui Medical Science's revenue in the last 12 month grew by 25%.
Inner Mongolia Furui Medical Science's revenue per employee in the last FY averaged $0.7M, while opex per employee averaged $0.4M for the same period.
Inner Mongolia Furui Medical Science Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 25% | XXX | 26% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 29% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 25% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.7M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 25% | XXX | 24% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 18% | XXX | 18% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 7% | XXX | 7% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 50% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Inner Mongolia Furui Medical Science Public Comps
See public comps and valuation multiples for other Medical Supplies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Inner Mongolia Furui Medical Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Shandong Weigao Blood | XXX | XXX | XXX | XXX | XXX | XXX |
| Dentsply Sirona | XXX | XXX | XXX | XXX | XXX | XXX |
| Chengzhi | XXX | XXX | XXX | XXX | XXX | XXX |
| Schott Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Ansell | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Inner Mongolia Furui Medical Science M&A Activity
Inner Mongolia Furui Medical Science acquired XXX companies to date.
Last acquisition by Inner Mongolia Furui Medical Science was on XXXXXXXX, XXXXX. Inner Mongolia Furui Medical Science acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Inner Mongolia Furui Medical Science
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialInner Mongolia Furui Medical Science Investment Activity
Inner Mongolia Furui Medical Science invested in XXX companies to date.
Inner Mongolia Furui Medical Science made its latest investment on XXXXXXXX, XXXXX. Inner Mongolia Furui Medical Science invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Inner Mongolia Furui Medical Science
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Inner Mongolia Furui Medical Science
| When was Inner Mongolia Furui Medical Science founded? | Inner Mongolia Furui Medical Science was founded in 1998. |
| Where is Inner Mongolia Furui Medical Science headquartered? | Inner Mongolia Furui Medical Science is headquartered in China. |
| How many employees does Inner Mongolia Furui Medical Science have? | As of today, Inner Mongolia Furui Medical Science has over 330 employees. |
| Is Inner Mongolia Furui Medical Science publicly listed? | Yes, Inner Mongolia Furui Medical Science is a public company listed on Shenzhen Stock Exchange. |
| What is the stock symbol of Inner Mongolia Furui Medical Science? | Inner Mongolia Furui Medical Science trades under 300049 ticker. |
| When did Inner Mongolia Furui Medical Science go public? | Inner Mongolia Furui Medical Science went public in 2010. |
| Who are competitors of Inner Mongolia Furui Medical Science? | Inner Mongolia Furui Medical Science main competitors are Shandong Weigao Blood, Dentsply Sirona, Chengzhi, Schott Pharma. |
| What is the current market cap of Inner Mongolia Furui Medical Science? | Inner Mongolia Furui Medical Science's current market cap is $2B. |
| What is the current revenue of Inner Mongolia Furui Medical Science? | Inner Mongolia Furui Medical Science's last 12 months revenue is $250M. |
| What is the current revenue growth of Inner Mongolia Furui Medical Science? | Inner Mongolia Furui Medical Science revenue growth (NTM/LTM) is 25%. |
| What is the current EV/Revenue multiple of Inner Mongolia Furui Medical Science? | Current revenue multiple of Inner Mongolia Furui Medical Science is 8.5x. |
| Is Inner Mongolia Furui Medical Science profitable? | Yes, Inner Mongolia Furui Medical Science is net-income-positive (as of the last 12 months). |
| What is the current net income of Inner Mongolia Furui Medical Science? | Inner Mongolia Furui Medical Science's last 12 months net income is $25M. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.